CAS9

Search documents
约20家A股公司涉足基因编辑领域
Zheng Quan Ri Bao· 2025-08-11 16:46
Group 1: Industry Overview - The new gene editing technology developed by the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences allows precise manipulation of large DNA segments ranging from thousands to millions of bases, significantly enhancing the scale and capability of gene editing [1] - The gene editing market is projected to reach an annual revenue of $30 billion by 2030, indicating a strong growth trajectory [2] - Gene editing technology is transitioning from theoretical research to practical applications, with significant implications in medicine for treating genetic diseases and in agriculture for developing new crop varieties [2] Group 2: Company Developments - Approximately 20 listed companies in the A-share market are involved in gene editing technology [3] - A company has established a cotton research institute in collaboration with Huazhong Agricultural University, utilizing gene editing and hybridization techniques for cotton seed development [3] - Another company is conducting research on the water buffalo genome and has developed a breeding model based on whole genome data analysis to enhance breeding efficiency [3] - A biotechnology company focuses on providing gene-modified animal models and related technical services for drug development and disease research, having developed over 21,000 models by the end of 2024 [3] - Beijing Baipu Sais Biotechnology Co., Ltd. has launched CAS series proteins for targeted gene editing applications [4]